Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 99, Issue 6, Pages 600-611Publisher
WILEY
DOI: 10.1002/cpt.363
Keywords
-
Categories
Funding
- NIAID NIH HHS [T32 AI052066] Funding Source: Medline
- NIDDK NIH HHS [R01 DK108366, R01 DK104047] Funding Source: Medline
Ask authors/readers for more resources
Human immunodeficiency virus (HIV) infection is associated with an altered gut microbiome that is not consistently restored with effective antiretroviral therapy (ART). Interpretation of the specific microbiome changes observed during HIV infection is complicated by factors like population, sample type, and ART-each of which may have dramatic effects on gut bacteria. Understanding how these factors shape the microbiome during HIV infection (which we refer to as the HIV-associated microbiome) is critical for defining its role in HIV disease, and for developing therapies that restore gut health during infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available